Sidekick Health

What Sidekick Health does

Sidekick Health is an Icelandic digital therapeutics company founded in 2014 that operates a multi-chronic condition management platform covering more than 20 therapeutic areas including oncology, dermatology, inflammatory bowel disease, rheumatoid arthritis, cardiovascular disease, obesity, and diabetes. The platform combines gamification, behavioral science, AI-driven personalization, medication reminders, and one-on-one lifestyle coaching, with reported median patient engagement of 6.5 days per week. Distribution is split across three channels: regulated prescription digital therapeutics (PDTs) including zanadio (weight management, listed in Germany's DiGA formulary with over 50,000 prescriptions) and PINK! Coach (breast cancer); enterprise platform subscriptions sold to international pharmaceutical companies such as Eli Lilly, Pfizer, AstraZeneca, Roche, and Bayer; and payer/employer contracts for multi-condition population management.

The underlying technology stack ingests digital biomarkers from smartphones and wearables—photoplethysmography-derived heart rate, accelerometry-based sleep and activity, gait sensors, and vocal characteristics—alongside self-reported symptom and behavioral data to support continuous risk monitoring and coaching workflows. The company generates revenue through subscription-based platform licensing to pharma, recurring payer/employer contracts (with projections of over 20% cost reduction per active participant), and per-prescription PDT reimbursement in Germany.

Sidekick has scaled through approximately $115 million in disclosed funding, including a $20M Series A led by Wellington Partners and Asabys Partners and a $55M Series B led by Novator Ventures in May 2022. A €35M venture debt facility from the European Investment Bank in May 2025 is earmarked for AI and platform expansion. The company has executed two strategic acquisitions—aidhere (October 2023, adding zanadio) and PINK! (June 2024, adding breast cancer DTx)—and operates from Reykjavik with offices in Berlin, Hamburg, and New York. Reported revenue tripled year-over-year prior to the 2022 Series B.

Name

Sidekick Health

Legal name

Sidekick Health ehf.

Website

https://sidekickhealth.com

Company type

Private

Founded year

2014

Operating status

Operating

Headcount range

101–250 employees

Short description

Sidekick Health is an Icelandic digital therapeutics company operating a multi-chronic condition management platform covering 20+ therapeutic areas for patients, pharmaceutical companies, payers, and employers, with PDTs distributed through Germany's DiGA formulary.

Ownership category

akta.pro rank

Product category

Digital Therapeutics

NAICS

Other Ambulatory Health Care Services (6219), Ambulatory Health Care Services (621)

SIC

Services-Prepackaged Software (7372), Services-Misc Health & Allied Services, Nec (8090)

akta.pro primary industry

Medication Adherence, Digital Therapeutics & Remote Coaching (condition-specific programs) (HLALAFAF)

akta.pro secondary industries

Chronic Condition Virtual Care & Disease Management (Payer-Sponsored) (HLALACAE), Adherence, Reminders & Engagement Automation (Medication/Follow-up) (HLACAEAJ), Remote Therapeutic Monitoring (RTM) & Digital Rehabilitation Platforms (HLALABAK)

Keywords

• Digital therapeutics
• Chronic disease management
• Digital health platform
• Prescription digital therapeutics
• Behavioral health software

Headquarters

HQ city

Reykjavík

HQ country

Iceland

HQ region

Europe

Offices4 records

Markets served

GTM type

B2B

Offering type

Software

Cost components

Personnel, Technology or R&D, Marketing or Sales, Operations, Infrastructure

Revenue model

1. Prescription Digital Therapeutics (PDT) licensing and prescriptions: Revenue from FDA/CE cleared prescription digital therapeutics prescribed by healthcare providers, including zanadio (Germany's DiGA formulary) and PINK! Coach for breast cancer patients
2. Platform subscription for pharma partners: B2B platform subscriptions and licensing deals with international pharmaceutical companies like Eli Lilly, Pfizer, and AstraZeneca for digital health solutions integrated into their therapy offerings
3. Payer and employer platform contracts: Health plan and employer contracts providing multi-chronic condition management platform with cost reduction outcomes (projecting over 20% cost reduction per active participant)

Go-to-market motion3 records

Distribution channels6 records

Marketing channels6 records

Core offering

Sidekick Health develops and delivers a digital therapeutics platform that integrates management of over 20 chronic conditions through gamification, behavioral science, and personalized care experiences. The company sells prescription digital therapeutics, B2B platform subscriptions to pharmaceutical companies and payers, and condition-specific DTx programs (atopic dermatitis, rheumatoid arthritis, IBD, oncology, MSK, breast cancer, peripheral artery disease).

Product overview

Sidekick Health is a digital health company offering a platform-based approach with a unified platform supporting over 20 chronic conditions. The portfolio consists of the core Sidekick Health Platform (multi-chronic condition management with gamification and behavioral science), acquired brands including PINK! Coach and PINK! Leben (breast cancer therapeutics), and zanadio (weight management DiGA), plus condition-specific DTx programs for atopic dermatitis, rheumatoid arthritis, IBD, oncology, cardiovascular, and MSK conditions. The company partners with pharmaceutical companies, payers, and healthcare providers to deliver digital therapeutics across Europe and North America.

Differentiator

Problem solved

Functional benefit

Brands

• zanadio: Prescription digital therapeutic (PDT) approved within Germany's regulated DiGA formulary for weight management
• PINK! Coach

Products and services

• Sidekick Health Platform Multi-chronic condition management platform integrating over 20 chronic conditions through gamification, behavioral science, and medication management tools. Provides personalized care experiences and serves health plans, employers, and healthcare providers.
• Sidekick Digital Therapeutics (DTx) Prescription digital therapeutics and lifestyle programs for managing chronic conditions including atopic dermatitis, rheumatoid arthritis, inflammatory bowel disease, oncology, cardiovascular disease, and metabolic conditions.
• zanadio Prescription digital therapeutic (PDT) approved within Germany's regulated DiGA formulary for weight management and obesity care. Prescribed over 50,000 times.
• PINK! Coach Prescribed digital therapeutic app for breast cancer patients in Germany providing psychosocial support and cancer care management for women with breast cancer.
• MSK Health Program Musculoskeletal health program and pain management support launched as part of the AI-powered intelligent care platform. Addresses one of the most common and costly health conditions affecting more than one in three adults.
• Whole-Person Care Platform (with MOBE) Comprehensive full-risk platform for managing multiple chronic conditions combining MOBE's human-led coaching with Sidekick Health's digital platform. Projects cost reductions exceeding 20% per active participant for health plans and employers.

Quantifiable outcome

• 44% improvement in eczema severity (SCORAD score) in 6-week pilot study
• +5 more outcomes

Named customers3 records

Segments4 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability6 records

Feature5 records

Partnerships

Ten partnerships are on record, tiered core, flagship and minor.

• MOBĒcoreStrategic or Co-development Partner · 21 April 2026Sidekick Health announced expansion of its intelligent care platform with musculoskeletal (MSK) health program and pain management support developed in collaboration with MOBĒ. The program integrates with 24+ existing conditions on a single platform, enabling health plans and employers to manage rising risk and multi-condition complexity.
• MOBEcoreStrategic or Co-development Partner · 13 January 2026MOBE, a whole-person health company, announced a partnership and strategic investment in Sidekick Health to deliver integrated care for individuals managing Multiple Chronic Conditions (MCC). The partnership combines MOBE's human-led coaching with Sidekick's digital platform supporting over 20 chronic conditions. Companies project sustained engagement, measurable health improvements, and cost reductions exceeding 20% per active participant for health plans and employers.
• CancerX / White HouseflagshipStrategic or Co-development Partner · 28 March 2023Sidekick Health was chosen as partner for the White House's CancerX project to rapidly accelerate the pace of cancer innovation in the U.S. This is a flagship national initiative for digital health cancer care innovation.
• InfectoPharm Digital Health GmbHminorChannel Partner/ Reseller/ DistributorPartnership for marketing and distribution of digital health application 'Meine Tinnitus App' through healthcare professional channels in Germany.
• Elona Health GmbHminorChannel Partner/ Reseller/ DistributorJoint marketing and distribution partnership for digital health applications under joint controllership agreement per Art. 26 GDPR.
• Eli LillycoreStrategic or Co-development PartnerExisting collaboration with Eli Lilly as one of the major pharma giants for digital health solutions and partnerships.
• PfizercoreStrategic or Co-development PartnerExisting collaboration with Pfizer as one of the major pharma giants. Previously announced landmark deal to roll out digital care platform in Europe.
• AstraZenecacoreStrategic or Co-development PartnerAstraZeneca partnership for integrating digital therapeutics into value creation, focusing on cardiovascular, renal, and metabolic portfolio.
• RochecoreStrategic or Co-development PartnerSelected as one of two startups out of 160 for presentation at Roche Innovation Summit. Partnership for rare conditions digital health solutions.
• BayercoreStrategic or Co-development PartnerSelected for Bayer G4A Dealmaker Day, Bayer's health technology partnership and acceleration program.

Scale indicators10 records

Recent moves6 records

Expansion highlights7 records

Direct peers

• Omada Health: Omada is a digital chronic condition management platform covering diabetes, hypertension, and musculoskeletal care, selling to payers and employers on a value-based contract model closely mirroring Sidekick's payer/employer GTM.
• Hinge Health: Hinge Health is the leading digital MSK and pain management platform sold to health plans and employers, directly overlapping with Sidekick's newly launched MSK program and shared payer contracting motion.
• Click Therapeutics: Click Therapeutics develops prescription digital therapeutics and software-enhanced drug therapies in partnership with major pharma (e.g., Otsuka, Boehringer Ingelheim), closely matching Sidekick's pharma-anchored PDT business model.
• WellDoc: WellDoc is an FDA-cleared digital therapeutic company focused on cardiometabolic conditions, with pharma and payer partnerships comparable to Sidekick's regulated, multi-condition DTx approach.
• Kaia Health: Kaia Health offers digital MSK and chronic pain programs delivered through employer and payer contracts, competing with Sidekick's MSK module in the same buyer ecosystem.
• Hello Better: Hello Better is a German digital therapeutics company with multiple DiGA-listed products for mental and behavioral health, operating in Sidekick's home reimbursement market with similar prescription-revenue mechanics.
• Sword Health: Sword Health provides AI-driven digital MSK and pelvic health programs to employers and health plans, directly competitive with Sidekick's MSK offering and the broader pain management category.
• DarioHealth: DarioHealth is a multi-condition digital therapeutics platform covering diabetes, hypertension, musculoskeletal, and behavioral health, sold to payers and employers with a B2B2C model similar to Sidekick's.
• mySugr (Roche): mySugr is a digital diabetes management app owned by Roche, combining chronic condition coaching with pharma-grade evidence generation in a model structurally similar to Sidekick's diabetes and cardiometabolic programs.
• Akili Interactive: Akili Interactive is an FDA-cleared prescription digital therapeutic company (initially for ADHD), representing the prescription DTx regulatory model and pharma distribution pathway that Sidekick also pursues through zanadio and PINK! Coach.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

• Xx.com/sidekickhealth
• YouTubeyoutube.com/channel/UCPRek5jiNWAEQtDhgCJECxA
• Facebookfacebook.com/sidekickhealth
• LinkedInlinkedin.com/company/sidekick-health
• Instagraminstagram.com/sidekickhealth

Revenue estimate

Valuation estimate

Number of profiles

Profiles5 records

Subsidiaries3 records

Funding overview

Funding rounds10 records

Investors7 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A2 records

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Sidekick Health